- Home
- EBON vs ANTX Comparison
EBON vs ANTX Comparison
Compare EBON & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- ANTX
- Stock Information
- Founded
- EBON 2010
- ANTX 2017
- Country
- EBON China
- ANTX United States
- Employees
- EBON N/A
- ANTX N/A
- Industry
- EBON Semiconductors
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- ANTX Health Care
- Exchange
- EBON Nasdaq
- ANTX Nasdaq
- Market Cap
- EBON 25.3M
- ANTX 33.2M
- IPO Year
- EBON 2020
- ANTX 2022
- Fundamental
- Price
- EBON $4.94
- ANTX $1.07
- Analyst Decision
- EBON
- ANTX Buy
- Analyst Count
- EBON 0
- ANTX 2
- Target Price
- EBON N/A
- ANTX $2.00
- AVG Volume (30 Days)
- EBON 31.3K
- ANTX 287.6K
- Earning Date
- EBON 08-22-2025
- ANTX 08-12-2025
- Dividend Yield
- EBON N/A
- ANTX N/A
- EPS Growth
- EBON N/A
- ANTX N/A
- EPS
- EBON N/A
- ANTX N/A
- Revenue
- EBON $5,868,771.00
- ANTX N/A
- Revenue This Year
- EBON N/A
- ANTX N/A
- Revenue Next Year
- EBON N/A
- ANTX N/A
- P/E Ratio
- EBON N/A
- ANTX N/A
- Revenue Growth
- EBON 20.88
- ANTX N/A
- 52 Week Low
- EBON $3.00
- ANTX $0.87
- 52 Week High
- EBON $10.94
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- EBON 75.89
- ANTX 42.84
- Support Level
- EBON $3.28
- ANTX $1.07
- Resistance Level
- EBON $3.49
- ANTX $1.11
- Average True Range (ATR)
- EBON 0.31
- ANTX 0.04
- MACD
- EBON 0.09
- ANTX 0.00
- Stochastic Oscillator
- EBON 95.54
- ANTX 7.14
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.